Inside You

Where the body makes its own peptides and how they carry messages.

Q15Inside You

Cagrilintide Dosage Reference From Trials to Approval Status

No established cagrilintide dosage exists. The drug and the CagriSema combination had no approval in the sources checked on October 22, 2026, so there is no label dose, only supervised trial amounts.

CagriSema was filed with the FDA in December 2025, and no approval was found as of October 22, 2026.
Trial amounts were set by protocol under supervision, so they are not home instructions.
REDEFINE 1 reported 20.4 percent weight loss with CagriSema against 3.0 percent with placebo.

Cagrilintide is a long acting analog of amylin, a satiety hormone. It has no approved label, alone or inside the combination CagriSema, which Novo Nordisk submitted to the FDA in December 2025. The 2021 phase 2 trial and the REDEFINE trials tested supervised amounts and reported weight loss with more stomach side effects. Without a label, no one can give a safe self directed dose, and vendor tables have no validated source.

Q20Inside You

How Long Does It Take Oxytocin to Work and How Long Does It Last

Only the hospital drip has a firm answer: the uterus responds almost at once and the effect fades within an hour. Nasal sprays have no approved timing and no established dose.

The Pitocin label says the uterus responds almost immediately to a drip and the effect fades within an hour.
In one small nasal study, blood levels peaked within minutes while spinal fluid levels rose later.
A large 24 week trial in autism found no benefit over placebo, so there is no onset to time.

Timing depends on the route. For the approved hospital drip, the label gives a response in moments and a half life of a few minutes. For a muscle injection it gives minutes to start and hours of effect. Nasal sprays are not covered by that label, and a small study found blood and brain fluid levels move on different clocks. A large autism trial found no benefit, so no schedule exists for self use.

Q27Inside You

Why MOTS c Dosage Cannot Be Settled as Daily or Weekly

Nobody can say, because no human half-life or schedule comparison for MOTS c has been published. Mouse studies and early trials show biology, not a safe rhythm for people.

A frequency needs a half-life, and no human half-life for MOTS c has been published.
Mouse studies chose their own patterns and never compared daily with weekly.
Early human trials test whether it works, not which schedule is best.

Daily versus weekly sounds like a simple choice, but a schedule is derived from how long a molecule stays in the blood, and that has not been measured for MOTS c in people. Mouse papers treated animals repeatedly to see biology, and registered human trials use one fixed regimen to test benefit. Charts online fill the gap with borrowed or invented numbers, so none can be called an established dose.

Q30Inside You

Where does the body get its own peptides?

From genes that code for a longer precursor. Enzymes then cut the precursor into one or several active peptides, often in storage vesicles just before release.

A gene makes a long precursor, not the finished peptide.
Enzymes cut at pairs of basic amino acids such as lysine and arginine.
One precursor can yield several different messengers.

The cell reads a gene and builds a long chain called a prepropeptide. A short leader sequence steers it into the secretory pathway and is removed. Prohormone convertases then snip the remainder at specific sites. Proinsulin becomes insulin plus a leftover C-peptide, and the precursor POMC is cut into several different hormones depending on the tissue.

Q31Inside You

Hormone or neurotransmitter: which is a peptide?

Either, and often both. A peptide is called a hormone when it travels through blood to far targets, and a neurotransmitter when it crosses the tiny gap between two nerve cells.

The label depends on the route taken, not on the molecule.
Oxytocin and vasopressin act as both.
Peptide signals tend to be slower and longer lasting than small-molecule ones.

The two words describe delivery. A neurotransmitter is released at a synapse, a gap about 20 nanometres wide, and acts on the neighbour. A hormone enters the bloodstream and reaches distant organs. Many peptides do both jobs, and neuropeptides can drift beyond the synapse and affect a wider area of tissue.

Q33Inside You

Why a Selank Dosage Chart Cannot Be Trusted Outside Its Russian Registration

No selank dose is established outside Russia, where a registered product exists, and online vials are not that product. The enkephalin research behind it is small and does not support a chart.

Selank is listed among peptide drugs registered in Russia as an anxiolytic, not in the US.
The enkephalin story rests on small Russian studies with active comparators.
FDA lists selank acetate as nominated but withdrawn and lacking safety information.

Selank is a seven amino acid analogue of tuftsin that Russian developers registered as an anxiolytic. Two older Russian studies point to effects on enkephalin breakdown, but the human work is small and used an active comparator. A registration in one country does not cover vials sold online, whose contents, form and route are unknown. FDA says it lacks important safety information, so a dose chart has no reliable source.

Q34Inside You

Sermorelin vs Tesamorelin and What Separates These Two GHRH Copies

Both are lab copies of growth hormone releasing hormone that act on the same receptor. Tesamorelin is the full length version with an added chemical tail and is approved for one condition, while sermorelin is a shorter piece whose brand products were discontinued in 2008.

Sermorelin is the first 29 amino acids, tesamorelin the full 44 with a hexenoyl group.
Tesamorelin is approved for excess abdominal fat in HIV lipodystrophy, not for general use.
Reddit threads and stack claims offer anecdotes, not head to head trials.

These two drugs belong to one family and share a receptor, so they are two versions of one signal rather than rival mechanisms. The tail on tesamorelin adds stability but the label still reports a half-life of about eleven minutes. Sermorelin's US brand products were discontinued in 2008 and FDA later said that was not for safety or effectiveness reasons. No trial compares them or tests a stack, so forum advice cannot settle the choice.

Q37Inside You

Vesugen Peptide Injection Cycle Length Mg per Day and What the Vessel Wall Evidence Shows

No cycle length or milligram amount exists for vesugen, because the KED tripeptide has no approval and no dose finding study. The evidence is cell work from one research group and one small human report without a placebo group.

Vesugen is the tripeptide Lys Glu Asp, studied mostly by one Russian research group.
Proposed actions, such as PEPT1 transport and DNA binding, are hypotheses, not proof.
The human report I verified had 41 patients and no placebo group, and it sets no protocol.

The lining of blood vessels, the endothelium, controls tone, stickiness and inflammation, and researchers study short peptides as possible signals there. Cell studies report that the KED tripeptide changes endothelial markers, and reviews propose that small peptides may enter cells through transporters such as PEPT1 or bind DNA. The one human report found was a small before and after study. No regulator has approved vesugen, so no cycle or daily amount can be stated.